A recent prospective study reported that higher concentrations of EPA were associated with a lower incidence of AD and a decreased risk for all-cause dementia and AD among apolipoprotein Eε4 (APOE ε4) noncarriers but not among APOEε4 carriers [61]. This evidence concerns the gene APOE and dementia.